Erythromycin Ambroxol Tablets can be administered to children with medical indications under the supervision of a physician and parental guardianship. Erythromycin Ambroxol Tablets are a combination of Erythromycin and Ambroxol Hydrochloride and are indicated for the treatment of acute bronchitis caused by sensitized bacteria requiring expectorant therapy, acute exacerbation of chronic bronchitis, and chronic bronchitis. Contraindications to the use of the drug include hypersensitivity to macrolides, ambroxol, bromhexine, pregnant or potentially pregnant women, breastfeeding women, as well as those taking the vasoconstrictor ergot alkaloids. Adverse drug reactions include nausea, vomiting, epigastric pain, diarrhea, constipation, dry mouth, rash, urticaria, angioneurotic edema, headache, dizziness, and weakness. Children are not contraindicated, so children who meet the indications can use the drug under parental supervision. Specific use of the drug should be carried out under the guidance of a specialist physician.